Clinique Pasteur — Clinical Trial Site

51 Registered trials

23 Currently recruiting

Organisation

Clinique Pasteur

Location

Toulouse Cedex 3, France

Identifier

ORG-100046819

Address

45 Avenue De Lombez, Cs 27617, 31076, France

Departments

Anaesthesia and Intensive Care
ANESTHESIE REANIMATION
Anesthésie-Réanimation
Cardiologie
CARDIOLOGY
Cardiology and cardio-thoracic and vascular surgery
Cardiology/EP
Centre hépato-biliaire Service de gastro-enterologie
Chirurgie Oncologique Gynécologique
Departement de Cardiologie
Département de radiothérapie
Gastro-enterology, Endoscopy and Hepatic Diseases
Gastro-hepato-entérologie
Gastroentérologie
Gastroenterology
Groupe CardioVasculaire Interventionnel
Interventional Cardiovascular Group
Medical Oncology
ONCOLOGIE
Oncology
Oncology - radiotherapy
Pneumology
Radiotherapy
Service de Gastro-Enterologie
Service gastro entérologie, endoscopie et maladies du foie
Service Oncologie Hématologie
Unity of Oncology and Hematology (ONCOSUD)
Urologie
Urology

Clinical trials at this site (51)

Search interface

PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy… Not authorised

2023-510191-31-00 Benign Prostate Hyperplasia 5
Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct… Pending

2024-518139-12-00 locally advanced or metastatic Pancreatic ductal adenoc 4
SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection… Pending

2024-518146-25-00 patients with atrial fibrillation and preserved left ve 5
Evaluating a Personalized Treatment Strategy for Young Women with Early Breast Cancer Pending

2024-519655-28-00 Premenopausal patients with high-risk HR-positive/HER2- 5
KARMA - INtenSive care TreAtmeNT with adjuvant KetAmine and Recovery after Mechanical ventilAtion: a multicenter doubleblind randomized cont… Pending

2025-523149-80-00 Adult patients admitted to the ICU and receiving unplan 10
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery: Impact on Postoperative Cardiovascular Outcomes Pending

2025-524395-30-00 heart failure 6
OPTIMAL CARE WITH GUSELKUMAB IN CROHN’S DISEASE Pending

2025-524573-16-00 Crohn's disease 6
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
HER2DX-guided diagnostic treatment For patients with HER2-positive early-stage breast cancer Recruiting

2025-521040-37-00 HER2-positive early breast cancer 5 2025-11-26
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obe… Recruiting

2024-520209-38-00 Obesity or Overweight 5 2025-09-19
PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with … Recruiting

2023-505046-26-00 Colon carcinoma 5 2026-05-07
DIAMOND Study - DIrect oral anticoagulant for Antithrombotic Management Of aortic bioprothesis implanted patients for valvular heart Disease… Recruiting

2024-516643-64-00 Aortic bioprothesis implanted patient for valvular hear 5 2026-03-13
Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting

2025-521805-41-00 Patients with HER2-positive, locally advanced or metast 5 2026-02-18
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn’s Disease and Obesity or Overweight:… Recruiting

2024-520210-21-00 Crohn’s Disease 5 2025-09-19
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-line Treatment of PD-L1-high Metastatic Non-small Cell Lung… Recruiting

2024-517780-24-00 Lung Cancer 5 2025-09-18
Personalizing the use of pembrolizumab for patients who have a strong response in early triple negative breast cancer Recruiting

2024-515787-31-00 Patient with early triple-negative breast cancer (TNBC) 5 2025-07-18
SUPPRESS. Prophylactic frequent premature ventricular complexeS sUPPression on left ventriculaR function impairmEnt in aSymptomatic patientS Recruiting

2024-516372-14-00 Asymptomatic Patients with frequent PVCs and normal LVE 11 2025-01-13
Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting

2023-509717-36-00 AF patients who have undergone successful PCI 5 2024-12-16
Short versus long antiplatelet therapy after TAVI Recruiting

2023-508208-40-00 All adult patients with successful transfemoral trans-a 10 2024-11-21
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting

2023-510395-31-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-10-30
Reduction in the number of chemotherapy cycles in combination with Pembrolizumab in first-line treatment of PD-L1-positive recurrent or meta… Recruiting

2024-514875-16-00 First-line treatment of PD-L1-positive recurrent or met 4 2024-10-21
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
SALVOVAR trial: A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose & dosing schedule with the SALVa… Recruiting

2023-508260-30-01 Patients with poor prognostic OVARian cancers based on 5 2024-07-30